Lotus Health Group (600186.SS) Earnings Analysis
Lotus Health Group (600186.SS) has no confirmed upcoming earnings date. Trailing P/E 44.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600186.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600186.SS. This page updates as the calendar is published.
600186.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-07 | 0.0265 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.05192 CNY | n/a | n/a | n/a |
| 2025-04-06 | 0.061 CNY | n/a | n/a | n/a |
| 2024-09-29 | 0.0359 CNY | n/a | n/a | n/a |
600186.SS valuation and analyst view
| Trailing P/E | 44.60 |
|---|---|
| Trailing EPS | 0.21589 CNY |
| Price / book | 7.51 |
| Dividend yield | 0.00% |
| Market cap | 15.35B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lotus Health Group (600186.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600186.SS. This page updates as the calendar is published.
Did 600186.SS beat earnings last quarter?
Consensus estimate data was not available for 600186.SS's 2026-04-07 report.
What is 600186.SS's current P/E ratio and EPS?
600186.SS trades at a trailing P/E of 44.60 on trailing EPS of 0.2158879917560169 CNY.
What do analysts rate 600186.SS?
600186.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.